ProPhase Labs, Inc.
General ticker "PRPH" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $101.9M (TTM average)
ProPhase Labs, Inc. does not follow the US Stock Market performance with the rate: -25.8%.
Estimated limits based on current volatility of 12.4%: low 0.11$, high 0.14$
Factors to consider:
- Total employees count: 129 as of 2022
- Top business risk factors: IT system failures, Infrastructure disruption, Cybersecurity threats, Liquidity and credit risks, Climate change and natural disasters
- Current price 96.2% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.39$, 13.08$]
- 2025-12-31 to 2026-12-31 estimated range: [3.58$, 10.36$]
Financial Metrics affecting the PRPH estimates:
- Negative: with PPE of -5.3 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of -1.32 <= -0.16
- Positive: Investing cash flow per share per price, % of 19.09 > -0.60
- Positive: Shareholder equity ratio, % of 11.63 <= 19.24
Short-term PRPH quotes
Long-term PRPH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $122.65MM | $44.38MM | $6.77MM |
| Operating Expenses | $99.05MM | $66.00MM | $45.40MM |
| Operating Income | $23.59MM | $-21.61MM | $-38.63MM |
| Non-Operating Income | $-0.69MM | $-0.79MM | $-3.70MM |
| Interest Expense | $0.76MM | $1.27MM | $3.35MM |
| R&D Expense | $0.65MM | $1.40MM | $0.59MM |
| Income(Loss) | $22.91MM | $-22.40MM | $-42.33MM |
| Taxes | $4.45MM | $-6.02MM | $7.20MM |
| Other Income(Loss) | $0.00MM | $-0.40MM | $-3.84MM |
| Net Income(Loss)* | $18.46MM | $-16.78MM | $-57.20MM |
| Stockholders Equity | $63.63MM | $49.38MM | $7.35MM |
| Inventory | $3.98MM | $2.29MM | $1.14MM |
| Assets | $87.65MM | $91.93MM | $63.20MM |
| Operating Cash Flow | $28.55MM | $-11.89MM | $-17.54MM |
| Capital expenditure | $3.92MM | $3.15MM | $0.91MM |
| Investing Cash Flow | $-2.08MM | $-1.37MM | $2.42MM |
| Financing Cash Flow | $-26.02MM | $5.76MM | $14.19MM |
| Earnings Per Share** | $11.65 | $-9.75 | $-29.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.